Nasdaq

Cepheid Selected by CDC as National Collaborator, Advancing Rapid Diagnostic Innovation to Strengthen U.S. Pandemic Preparedness

SUNNYVALE, Calif. , Feb. 18, 2026 /PRNewswire/ -- Cepheid today announced that it has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators ...
FierceBiotech

Cepheid, BioGX partner on PCR tests as monkeypox spreads

Though the global number of recorded monkeypox cases continues to climb—passing 4,100 last week, according to the Centers for Disease Control and Prevention (CDC)—many researchers and epidemiologists ...
The Business Journals

Birmingham-based BioGX developing PCR test for monkeypox

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. A Birmingham company is working with Cepheid to develop a ...
Business Wire

Fleming Initiative and Cepheid Launch Landmark Study of Rapid Testing for Drug-Resistant Infections

30-month real-world study at two London NHS Trusts to evaluate how rapid CPE screening can improve clinical practice and inform NHS and national AMR policy LONDON & SUNNYVALE, Calif.--(BUSINESS WIRE)- ...
Reuters

WHO lists two more mpox diagnostic tests for emergency use

Oct 30 (Reuters) - The World Health Organization said on Wednesday it has listed two additional mpox in-vitro diagnostic tests for emergency use. Xpert Mpox, a real-time PCR test manufactured by ...
Business Insider

Cepheid Receives Emergency Use Authorization from FDA for Xpert® Mpox

SUNNYVALE, Calif., Feb. 14, 2023 /PRNewswire/ -- Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration for Xpert Mpox, which runs on ...